TF and breast cancer: Although TF antigen roles in cancer are not completely understood (mainly due to different glycosylation patterns in different types of cancers), the pancarcinoma expression may have clinical utility as a potential immunotherapy target, leaving a possible glimmer of hope against recurrence of advanced BC[57].